Tabid, Dan Aiza .

HRN: 20-46-76  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/29/2022
CEFUROXIME 750MG (VIAL)
09/29/2022
10/06/2022
IVTT
285mg
Q12h
Pcap
Waiting Final Action 
09/30/2022
CEFTRIAXONE 1G (VIAL)
09/30/2022
10/07/2022
IVT
850 Mg
24 Hrs
Complex Febrile Seizure; Pcap C
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: